Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 2, 2006, Pages 374-380

  Lin, Shi De ^a   Kawakami, Tadashi ^b   Ushio, Akira ^a   Sato, Akihiro ^a   Sato, Sin Ichiro ^a   Iwai, Masakatsu ^a   Endo, Ryujin ^a   Takikawa, Yasuhiro ^a   Suzuki, Kazuyuki ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

^b Hokkaido Prefectural Esashi Hospital   (Japan)

Author keywords

Activin A; Acute hepatitis; Acute liver failure; Follistatin; Liver regeneration

Indexed keywords

ACTIVIN A; FOLLISTATIN;

ACUTE HEPATITIS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; LIVER FAILURE; LIVER INJURY; LIVER REGENERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; STATISTICAL SIGNIFICANCE;

EID: 33645238923     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.04036.x     Document Type: Article

References (26)

1. Welt C Sidis Y Keutmann H Schneyer A Activin A, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium ExpBiolMed 2002 227 724 52
2. Yasuda H Mine T Shibata H et al. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes JClinInvest 1993 92 1491 6
3. De Bleser PJ Niki T Xu G Rogiers V Geerts A Localization and cellular sources of activins in normal and fibrotic rat liver Hepatology 1997 26 905 12
4. Ichikawa T Zhang YQ Kogure K et al. Transforming growth factor β and activin A tonically inhibit DNA synthesis in the rat liver Hepatology 2001 34 918 25
5. Schwall RH Robbins K Jardieu P Chang L Lai C Terrell TG Activin A induces cell death in hepatocytes in vivo and in vitro Hepatology 1993 18 347 56
6. Kogure K Zhang YQ Maeshima A Suzuki K Kuwano H Kojima I The role of activin A and transforming growth factor β in the regulation of organ mass in the rat liver Hepatology 2000 31 916 21
7. Hashimoto O Nakamura T Shoji H Shimasaki S Hayashi Y Sugino H A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells JBiolChem 1997 272 13835 42
8. Sugino H Sugino K Hashimoto O Shoji H Nakamura T Follistatin and its role as an activin-binding protein JMedInvest 1997 44 1 44
9. De Winter JP ten Dijke P de Vries CJM et al. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors MolCellEndocrinol 1996 116 105 14
10. Kogure K Omata W Kanzaki M et al. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats Gastroenterology 1995 108 1136 42
11. Zhang YQ Mashima H Kanzaki M Shibata H Kojima I Assessment of the role of activin A and transforming growth factor β in the regulation of AML12 cell growth Hepatology 1997 25 1370 5
12. Sherlock S Portal venous 'goodies' and fulminant viral hepatitis NEnglJMed 1976 295 1535 6
13. Shiota G Okano J Kawasaki H Kawamoto T Nakamura T Serum hepatocyte growth factor levels in liver diseases: clinical implications Hepatology 1995 21 106 12
14. Tsubouchi H Hirono S Gohda E et al. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure Hepatology 1989 9 875 81
15. Shi Q Gaylor JD Cousins R Plevris J Hayes PC Grant MH The effects of serum from patients with acute liver failure on the growth and metabolism of HepG2 cells ArtifOrgans 1998 22 1023 30
16. Hughes RD Yamada H Gove CD Williams R Inhibitors of hepatic DNA synthesis in fulminant hepatic failure DigDisSci 1991 36 816 19
17. Sato S Murakami A Yoshida T Kashiwabara T Suzuki K Kaito I Usefulness of antithrombin III and α2-plasmin inhibitor in early differentiation of fulminant hepatitis and severe form of acute hepatitis GastroenterolJpn 1983 18 128 36
18. Trey C Davidson CS The management of fulminant hepatic failure. In: Popper H Schaffer F, eds Progress in Liver Diseases New York Grune & Stratton 1970; 282 98
19. Takahashi Y Shimizu M Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentre study. The study Group of Fulminant Hepatitis JGastroenterolHepatol 1991 6 159 64
20. Hughes RD Evans LW Activin A and follistatin in acute liver failure EurJGastroenterol 2003 15 127 31
21. Bernal W Wendon J Liver transplantation in adults with acute liver failure JHepatol 2004 40 192 7
22. Tsubouchi H Kawakami S Hirono S et al. Prediction of outcome in fulminant hepatic failure by serum human hepatocyte growth factor Lancet 1992 340 370
23. D'Errico A Fiorentino M Ponzetto A et al. Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does Hepatology 1996 24 60 4
24. Depaolo LV Bicsak TA Erickson GF Shimasaki S Ling N Follistatin and activin A: a potential intrinsic regulatory system within diverse tissues ProcSocExpBiolMed 1991 198 500 12
25. Abe M Shintani Y Eto Y et al. Interleukin 1β enhances and interferon-γ suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fibroblasts ClinExpImmunol 2001 126 64 8
26. Russell CE Hedger MP Brauman JN de Kretser DM Phillips DJ Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2 MolCellEndocrinol 1999 148 129 36